Skip to main content

Table 2 DAVID Functional Annotation Charts, 2-h and 18-h Severe PE verses Vehicle

From: Differential effect of mild and severe pulmonary embolism on the rat lung transcriptome

Category

Term

a2-h Severe PE verses Vehicle

18-h Severe PE verses Vehicle

Ct

%

Dir

Fold

B&H

Ct

%

Dir

Fold

B&H

SP_PIR

acetylation

     

183

17.72

UP

1.86

0.000

SP_PIR

activator

7

7.29

UP

5.58

0.025

     

SP_PIR

acute phase

     

7

0.68

UP

4.89

0.047

rno00520

Amino sugar and nucleotide

sugar metabolism

     

12

1.16

UP

4.37

0.002

rno00970

Aminoacyl-tRNA biosynthesis

     

12

1.16

UP

4.70

0.002

SP_PIR

Aminoacyl-tRNA synthetase

     

10

0.97

UP

5.11

0.003

rno00330

Arginine and proline metabolism

     

11

1.06

UP

3.25

0.046

rno05412

Arrhythmogenic right ventricular

cardiomyopathy (ARVC)

     

15

0.96

D

2.56

0.040

rno05217

Basal cell carcinoma

     

12

0.77

D

2.97

0.036

IPR011700

Basic leucine zipper

4

4.17

UP

41.80

0.004

     

IPR004827

Basic-leucine zipper (bZIP) transcription factor

8

8.33

UP

28.54

0.000

     

SM00338

BRLZ

8

8.33

UP

20.66

0.000

     

IPR011616

bZIP transcription factor, bZIP-1

4

4.17

UP

25.44

0.015

     

SP_PIR

Chaperone

     

18

1.74

UP

2.78

0.006

SP_PIR

chemotaxis

4

4.17

UP

20.78

0.025

9

0.87

UP

4.43

0.016

SP_PIR

Cholesterol biosynthesis

     

9

0.87

UP

7.47

0.000

rno04610

Complement and coagulation cascades

     

17

1.65

UP

3.80

0.000

SP_PIR

cytokine

9

9.38

UP

15.21

0.000

     

SP_PIR

DNA binding

6

6.25

UP

7.38

0.028

     

SP_PIR

dna-binding

15

15.63

UP

3.75

0.002

     

UP_SEQ

DNA-binding region: Basic motif

10

10.42

UP

15.44

0.000

     

UP_SEQ

domain: Leucine-zipper

9

9.38

UP

19.96

0.000

     

rno00982

Drug metabolism

     

20

1.28

D

3.51

0.000

rno04512

ECM-receptor interaction

     

17

1.09

D

2.65

0.020

SM00180

EGF_Lam

     

9

0.58

D

5.44

0.020

IPR002049

EGF-like, laminin

     

9

0.58

D

5.98

0.026

SP_PIR

endoplasmic reticulum

     

63

6.10

UP

2.04

0.000

PIRSF001719

fos transforming protein

4

4.17

UP

109.2

0.000

     

IPR000837

Fos transforming protein

4

4.17

UP

83.59

0.001

     

rno00480

Glutathione metabolism

     

12

0.77

D

3.03

0.041

rno00340

Histidine metabolism

     

9

0.58

D

4.73

0.019

SP_PIR

inflammatory response

4

4.17

UP

16.51

0.027

13

1.26

UP

5.08

0.000

SP_PIR

Initiation factor

     

12

1.16

UP

4.55

0.002

SP_PIR

Isomerase

     

17

1.65

UP

3.14

0.003

SP_PIR

lipid synthesis

     

19

1.84

UP

3.82

0.000

rno00980

Metabolism of xenobiotics by cyt. P450

     

18

1.15

D

3.79

0.000

UP_SEQ

mutagenesis site

     

59

3.77

D

1.75

0.042

rno04621

NOD-like receptor signaling pathway

5

5.21

UP

12.52

0.034

     

SP_PIR

nucleotide-binding

     

99

9.58

UP

1.36

0.024

SP_PIR

nucleus

22

22.92

UP

2.01

0.026

     

SP_PIR

phosphoprotein

     

##

27.49

UP

1.24

0.000

IPR011993

Pleckstrin homology-type

     

32

2.05

D

2.27

0.027

SP_PIR

protein biosynthesis

     

22

2.13

UP

2.04

0.049

SP_PIR

protein transport

     

34

3.29

UP

1.87

0.016

SP_PIR

Redox-active center

     

10

0.97

UP

4.74

0.005

SP_PIR

ribosome biogenesis

     

8

0.77

UP

5.31

0.014

SP_PIR

rna-binding

     

33

3.19

UP

2.16

0.002

SM00360

RRM

     

21

2.03

UP

2.69

0.015

SM00199

SCY

5

5.21

UP

18.26

0.003

     

IPR001811

Small chemokine, interleukin-8-like

5

5.21

UP

25.22

0.002

     

SP_PIR

Steroid biosynthesis

     

13

1.26

UP

5.08

0.000

rno00100

Steroid biosynthesis

     

9

0.87

UP

8.29

0.001

SP_PIR

sterol biosynthesis

     

11

1.06

UP

7.31

0.000

SP_PIR

Transcription

14

14.58

UP

3.23

0.009

     

SP_PIR

transcription regulation

14

14.58

UP

3.48

0.006

     

SP_PIR

translocation

     

11

1.06

UP

3.75

0.014

rno00350

Tyrosine metabolism

     

10

0.64

D

3.71

0.032

  1. Functional annotations significantly over-represented in the lists of up-regulated and down- regulated genes during 2-h and 18-h High-PE. Annotations unique to High-PE are highlighted in bold italics; annotations common to High-PE and Low-PE (Table 1) are in standard font. All other keys are the same as in Table 1. aNo 2-h DOWN annotations meet B&H < 0.05